You are seeing a new patient taking

You are seeing a new patient taking sulfasalazine (Azulfidine; ASA) for his Inflammatory Bowel Disease (IBD). Given the medication’s side effect profile, you make sure that the patient is taking supplemental: Group of answer choices Calcium Iron Folic Acid Vitamin B12 A patient with a history of chronic obstructive pulmonary disease (COPD) comes in complaining of increased shortness of breath (SOB), increased sputum production without color change, and increased cough. Based on this presentation, the initial differential priority is identified as: Congestive heart failure (CHF) Pneumonia Acute exacerbation Upper respiratory infection What should be considered in all patients with adult-onset asthma or in patients with asthma that worsens in adulthood? A suppressed immune system Another immunologic disease Concurrent COPD Occupational asthma A patient calls requesting a refill on his beta-2 agonist inhaler because he has run out again. Since he is unknown to you, you review his chart and see that he has mild persistent asthma, and this is the third time he has called in this month for a refill. Given this information, your next BEST step is: Start him on a long-acting B-agonist and reschedule him for follow-up in a month Suggest he come in for an office visit tomorrow to discuss his overall plan of management Call him, have him check his peak flow readings daily for the next week and call back with the results; call in a refill Start him on an inhaled steroid given that he has an inflammatory illness that is clearly uncontrolled The primary difference between Crohn’s disease and Ulcerative Colitis is that Crohn’s disease: Is an inflammatory disease rather than a functional disorder Is characterized by transmural lesions anywhere in the GI tract Is typically confined to the large bowel Frequently causes bloody diarrhea

******CLICK ORDER NOW BELOW AND OUR WRITERS WILL WRITE AN ANSWER TO THIS ASSIGNMENT OR ANY OTHER ASSIGNMENT, DISCUSSION, ESSAY, HOMEWORK OR QUESTION YOU MAY HAVE. OUR PAPERS ARE PLAGIARISM FREE*******."